Clinical Trials Directory

Trials / Completed

CompletedNCT05366907

Open Cholecystectomy Among Patients Undergoing Laparoscopic Cholecystectomy.

Open Cholecystectomy Among Patients Undergoing Laparoscopic Cholecystectomy in a Tertiary Care Centre: A Descriptive Cross-Sectional Study

Status
Completed
Phase
Study type
Observational
Enrollment
345 (actual)
Sponsor
Chitwan Medical College · Academic / Other
Sex
All
Age
10 Years – 75 Years
Healthy volunteers
Not accepted

Summary

In the current era, laparoscopic cholecystectomy is the treatment of choice for symptomatic gallstone disease. The aim of this study is to find out the prevalence of open cholecystectomy among patients undergoing laparoscopic cholecystectomy in a tertiary care center.

Detailed description

Laparoscopic Cholecystectomy (LC) is the gold standard surgery for symptomatic cholelithiasis with low mortality and morbidity.1,2 However, 1% to 15% of conversion rate to Open Cholecystectomy (OC) during laparoscopic cholecystectomy has been reported.3 Converted cases were associated with increased perioperative time, complication rates, perioperative costs, the length of hospital stay, and a higher 30-day readmission rate.3,4 Conversion was also associated with complications including bile leak, bile duct injury, or bleeding, requiring reoperation or transfusion, and death. A recent detailed critical review found that preoperative variables like male gender, older age, high body mass index, previous abdominal surgery, the severity of cholecystitis, and gallbladder wall thickness were associated with the higher rate of conversion to OC.4 However, data regarding its prevalence lacking in our setting. The aim of this study is to find out the prevalence of open cholecystectomy among patients undergoing laparoscopic cholecystectomy in a tertiary care centre.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention is doneIt is a descriptive cross-sectional study so no groups like case/controls are present. All the cases are included in the study.

Timeline

Start date
2020-06-01
Primary completion
2021-05-30
Completion
2021-12-30
First posted
2022-05-09
Last updated
2023-09-15

Locations

1 site across 1 country: Nepal

Source: ClinicalTrials.gov record NCT05366907. Inclusion in this directory is not an endorsement.